Diamyd Medical AB (publ)
DYMDF
$0.73
$0.000.00%
OTC PK
| 05/31/2025 | 02/28/2025 | 11/30/2024 | 08/31/2024 | 05/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -18.55% | -44.59% | -14.50% | -35.02% | -90.11% |
| Total Depreciation and Amortization | 23.77% | 16.96% | 21.12% | 13.65% | 18.73% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -3,146.85% | -105.89% | -307.83% | 359.09% | 109.51% |
| Change in Net Operating Assets | 28.26% | 49.07% | -286.43% | 1,984.96% | 150.83% |
| Cash from Operations | -28.07% | -28.80% | -56.07% | 13.99% | -50.05% |
| Capital Expenditure | -710.12% | 87.57% | 14.42% | 74.98% | 80.82% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 101.10% | -- | -- | -- | -60,409.84% |
| Cash from Investing | 88.49% | 87.57% | 847.61% | 900.36% | -1,108.74% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 366.62% | -- | -38.37% | -100.00% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -303.56% | -203.83% | 177.23% | -107.44% | -- |
| Cash from Financing | 356.35% | -186.63% | -25.13% | -100.99% | -- |
| Foreign Exchange rate Adjustments | 289.92% | 178.33% | 20.38% | 59.32% | -60.15% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1,752.85% | -17.03% | -15.34% | -120.83% | 43.11% |